Pfizer (PFE) Financial Analysis & Valuation | Quarter Chart
Pfizer (PFE)
PFEPrice: $24.39
Fair Value: 🔒
🔒score
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, smal... more
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical pro... more
Description
Shares
| Market Cap | $138.98B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | US | CEO | Albert Bourla |
| IPO Date | 1972-06-01 | CAGR | 0.07% |
| Employees | 81,000 | Website | www.pfizer.com |
| Div. Yield | 7.62% | Payout Ratio | 1.31% |
| Buy Back Yield | — | Total Yield | 7.62% |
PFE chart loading...
Fundamentals
Technicals
| Enterprise Value | $209.91B | P/E Ratio | 7.97 |
| Forward P/E | 8.61 | PEG Ratio | -1.84 |
| P/S Ratio | 2.03 | P/B Ratio | 1.43 |
| P/CF Ratio | 10.72 | P/FCF Ratio | 13.53 |
| EPS | $3.06 | EPS Growth 1Y | -5.05% |
| EPS Growth 3Y | -74.18% | EPS Growth 5Y | -30.79% |
| Revenue Growth 1Y | 1.36% | Gross Margin | 0.69% |
| Operating Margin | 0.23% | Profit Margin | 0.12% |
| ROE | 0.08% | ROA | 0.04% |
| ROCE | 0.09% | Current Ratio | 1.25 |
| Quick Ratio | 0.94 | Cash Ratio | 0.05 |
| Debt/Equity | 0.72 | Interest Coverage | 5.53 |
| Altman Z Score | 2.03 | Piotroski Score | 5 |